Tuberculosis and HIV Coinfection: Genesis of the Supplement and Sponsors' Contribution

August 2007
Journal of Infectious Diseases;8/15/2007 Supplement, Vol. 196, pS4
Academic Journal
No abstract available.


Related Articles

  • An estimate of the contribution of HIV infection to the recent rise in tuberculosis in England and Wales. Rose, A. M. C.; Sinka, K.; Watson, J. M.; Mortimer, J. Y.; Charlett, A. // Thorax;May2002, Vol. 57 Issue 5, p442 

    Background: The number of patients with tuberculosis has been increasing slowly in England and Wales since the late 1980s. HIV infection has been a contributory factor to increases in tuberculosis in a number of comparable industrialised countries. This study investigated the extent of...

  • Alternative therapy.  // Presidents & Prime Ministers;Mar/Apr98, Vol. 7 Issue 2, p33 

    Reports that an international study found that an effective alternative to the year-long regimen prescribed for persons co-infected with human immuno-deficiency virus (HIV) and tuberculosis (TB), is a two-month course of therapy to prevent active TB. Health organizations and centers who...

  • Immunology of AIDS Virus and Mycobacterial Co-Infection. Chen, Zheng W. // Current HIV Research;Oct2004, Vol. 2 Issue 4, p351 

    While detrimental consequences of biological interaction between HIV and M. tuberculosis are well described, immune mechanisms underlying the evolution of HIV and mycobacterial coinfection remain poorly characterized. Recent studies in HIV-infected humans and SIV-infected monkeys have enhanced...

  • The growing impact of HIV infection on the epidemiology of tuberculosis in England and Wales: 1999-2003. Ahmed, Aliko B.; Abubakar, Ibrahim; Delpech, Valerie; Lipman, Marc; Boccia, Delia; Forde, Josh; Antoine, Delphine; Watson, John M. // Thorax;Aug2007, Vol. 62 Issue 8, p672 

    Background: Previous studies have estimated the prevalence of tuberculosis and HIV infection in population subgroups in the UK. This study was undertaken to describe recent trends in the proportion of individuals with HIV infection among reported cases of tuberculosis in England and Wales, and...

  • Reply to Lu et al. Dheda, Keertan; Lampe, Fiona; Lipman, Marc C.; Johnson, Margaret A.; Rook, Graham A. W. // Journal of Infectious Diseases;11/1/2005, Vol. 192 Issue 9, p1674 

    Presents a letter to the editor commenting on the complex treatment-related issues for patients co-infected with HIV and Mycobacterium tuberculosis.

  • High Tuberculosis and HIV Coinfection Rate, Johannesburg. John, Melanie-Anne; Menezes, Colin Nigel; Chita, Gajendra; Sanne, Ian; Grobusch, Martin Peter // Emerging Infectious Diseases;May2007, Vol. 13 Issue 5, p795 

    A letter to the editor about a study on the rate of tuberculosis and human immunodeficiency virus (HIV) coinfection in Johannesburg, South Africa is presented.

  • Factors influencing delay in initiating antiretroviral therapy among HIV infected patients coinfected with tuberculosis. Chilton, D.; Edwards, S. G.; Pellegrino, P.; Miller, R. F. // Thorax;Oct2008, Vol. 63 Issue 10, p935 

    A letter to the editor is presented in response to the article on factors that influences the delay in antiretroviral therapy among patients infected with HIV coinfected with tuberculosis.

  • Co-Infection with Mycobacterium tuberculosis Impairs HIV-Specific CD8+ and CD4+ T Cell Functionality. Chetty, Shivan; Govender, Pamla; Zupkosky, Jennifer; Pillay, Mona; Ghebremichael, Musie; Moosa, Mahomed-Yunus S.; Ndung’u, Thumbi; Porichis, Filippos; Kasprowicz, Victoria O. // PLoS ONE;Mar2015, Vol. 10 Issue 3, p1 

    The ability of antigen-specific T cells to simultaneously produce multiple cytokines is thought to correlate with the functional capacity and efficacy of T cells. These ‘polyfunctional’ T cells have been associated with control of HIV. We aimed to assess the impact of co-infection...

  • HIV-1 Infection of Macrophages Dysregulates Innate Immune Responses to Mycobacterium tuberculosis by Inhibition of Interleukin-10. Tomlinson, Gillian S.; Bell, Lucy C. K.; Walker, Naomi F.; Tsang, Jhen; Brown, Jeremy S.; Breen, Ronan; Lipman, Marc; Katz, David R.; Miller, Robert F.; Chain, Benjamin M.; Elkington, Paul T. G.; Noursadeghi, Mahdad // Journal of Infectious Diseases;Apr2014, Vol. 209 Issue 7, p1055 

    Human immunodeficiency virus (HIV)–1 and Mycobacterium tuberculosis (M. tuberculosis) both target macrophages, which are key cells in inflammatory responses and their resolution. Therefore, we tested the hypothesis that HIV-1 may modulate macrophage responses to coinfection with M....

  • Acceptance of a ready-to-use supplementary food by stable HIV-treated and HIV and tuberculosis (co-infected)-treated patients. Pillay, Kirthee; Siwela, M.; Veldman, F. J.; Amonsou, E. O.; Mabaso, B. P. // South African Journal of Clinical Nutrition;2014, Vol. 27 Issue 1, p31 

    Objectives: The objective of the study was to determine consumer acceptance and perceptions of a ready-to-use supplementary food (RUSF) by subjects treated for human immunodeficiency virus (HIV) and HIV and tuberculosis (co-infected subjects). Design: A cross-sectional study was conducted....


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics